CD8A and neoplasm: Using a T‐cell lymphoma model, we demonstrate that nanoSTING@Mn robustly triggers infiltration of CD8+ T cells and monocytes into tumors, driving M1‐like macrophage polarization, suppressing Treg cells, and remodeling the immunosuppressive tumor microenvironment.